CPNP is the EU cosmetic notification system. Identify the responsible person and actual product before preparing the submission. This guide separates factory inputs, the RP’s controlled file and portal information; it does not verify a LAEYO EU entity, regulatory team or notification service.
What is CPNP and Why It Matters for Perfume
CPNP means Cosmetic Products Notification Portal. Article 13 requires the applicable product information before market placement; the Commission also identifies distributor submissions in specified circumstances. Confirm the actual body-fragrance classification and supply activity rather than applying the route to every fragrance-related item.
Notification is information submission, not pre-market approval. It does not replace the safety assessment, PIF, labeling, manufacturing and other applicable obligations. The Commission makes notified information available to competent authorities and poison centres for their roles.
- Confirm that the actual format, intended use and claims fall within cosmetics.
- Assign the legally eligible RP and authorized portal user, including any relevant distributor duties.
- Complete the applicable notification before market placement and other duties at their required stages.
- Do not treat notification completion as product approval or a guarantee against enforcement.
Step-by-Step CPNP Notification Process for Perfumes
Use the current official instructions with the authorized responsible person or relevant distributor. The following is a preparation workflow, not a verified screen-by-screen portal walkthrough or guaranteed processing time:
- Identify the RP: Verify establishment, statutory role and written designation/acceptance where required; an eligible importer may already have the role.
- Prepare the controlled file: Ensure the required safety/PIF work and access arrangements. This is not synonymous with uploading the entire file to CPNP.
- Prepare portal information: Use the current Article 13 and official manual requirements for identity/category, RP/contact, applicable origin/market, relevant substances and formulation information.
- Authorized access: The designated user follows official access and submission instructions; no 24/7 availability or particular screen behavior is guaranteed here.
- Submit and record: Verify the actual submission status and version; do not equate a draft or reference with product approval.
- Maintain information: Assess changes and complete required updates without delay under applicable instructions; record why an update or new record is appropriate.
The table distinguishes actual information objects from illustrative placeholders. It names no verified LAEYO EU company or approved product:
| Information object | What to establish | Illustrative placeholder, not real data |
|---|---|---|
| Product identity/category | Actual marketed product and category | Product A / category to confirm |
| Formulation information | Appropriate current portal route; not a brand code | RP/qualified reviewer decision ___ |
| RP and urgent contact | Verified eligible legal person and authorized contacts | RP legal name/address ___; no assumed LAEYO BV |
| Origin and market | Applicable import origin and first-market information | Actual country ___ |
| CMR/nanomaterial information | Actual composition and applicable notifications | Assessment result ___; do not prefill “none” |
| Label/package record | Correct approved versions and current required format | Artwork/image version ___ |
Documents and Information You’ll Need
Keep factory-provided records, RP-held safety/file material and portal-submitted information separate. The entire PIF and full proprietary formula are not automatically uploaded merely because the assessor needs access. Assign the following preparation topics:
- Full labeling artwork – front, back, box (in all languages required by member states where you’ll sell).
- Composition: Arrange secure assessor/RP access to sufficient formula data; use the appropriate portal formulation route, not an assumed universal full-compound upload.
- CPSR: Current signed product-specific report held within the required file; not a universal portal attachment.
- Proof of GMP compliance – statement or certificate from manufacturer.
- For perfumes containing ethanol: Arrange relevant denaturant/composition information for qualified safety review and answer the portal’s applicable formulation questions. No standalone denaturing-certificate upload is asserted.
- Fragrance/allergen information: Current complete-formula assessment and label mapping, not an old 26-only checklist.
- RP arrangement: Role evidence and written mandate/acceptance where required for the chosen arrangement.
Deadlines and Responsibilities
- Timing: Complete required notification before market placement. Build preparation dates from real data/review dependencies; no universal eight-to-ten-week lead time.
- Changes: Log formula, label, supplier and RP changes; assess affected safety/file/portal records. Not every change automatically requires an entirely new CPSR, PIF and notification.
- RP duties: Maintain required PIF access and ten-year retention from last-batch market placement, plus relevant post-market duties. Other parties retain their own obligations.
- Portal operator: Confirm the authorized RP user or applicable distributor route; legal role and delegated data entry are different.
Common Pitfalls to Avoid
- Incomplete composition review: Resolve the data needed for safety, label and portal purposes separately; no automatic limonene/linalool portal flag is verified.
- Identity mismatch: Reconcile actual RP details, file location and label records. Investigate discrepancies rather than predicting automatic rejection from a postcode typo.
- Incorrect formulation route: A frame formulation concerns ingredient categories/functions and maximum concentrations or relevant composition information under the regulatory definition; it is not merely a trade-name grouping.
- Uncontrolled change: Ask the RP to determine the required record action using actual differences and current guidance.
- Unverified supplier role: Confirm an eligible RP; an overseas factory’s assistance alone does not meet that role.
- Unassessed variant: Ensure each actual composition/package/use is within the qualified report scope and applicable file; document needed updates before market placement.
Blank handover checklist by information destination
| Information destination | Record scope | Owner / version / receipt and verification |
|---|---|---|
| Factory inputs | Formula/material/package/process records and agreed studies | Supplier ___; version ___; secure access ___; gaps ___ |
| RP-held file | Product description, CPSR, manufacturing/GMP, applicable claims and animal-testing information | RP/compiler ___; file version ___; assessor/signature ___ |
| Portal submission | Only applicable Article 13/other required information under current instructions | Authorized user ___; product/formulation route ___; submission/version ___ |
| Change control | Affected product/formula/label/RP records and decision | Reviewer ___; action ___; completion date ___ |
These are blank placeholders, not redacted authentic filings. Source check: 10 October 2026, Commission CPNP page and Cosmetics Regulation. The Commission’s 18 March 2026 Article 13 user guide was read on 11 October 2026. Pages 18–21 cover product identity, marketed language versions, contacts and origin/market information. Pages 30–35 distinguish predefined frame formulation, exact concentration and concentration-range routes; selecting a formulation name alone does not select the frame route. The full composition must fit the selected frame and the required additional ingredient information must be supplied. Page 38 addresses notifications covering several pack sizes or shades: attach the most legible original labelling/packaging, usually the largest pack. This is not automatic coverage for every same-brand SKU. Pages 43–44 distinguish updating previously valid information from correcting an error; apply the relevant formulation-route update criteria and record the decision. No portal login or filing is represented here.
Frequently Asked Questions
Do I need to notify a perfume sample or tester?
Assess whether the actual sample/tester is a cosmetic made available in a commercial activity; free supply does not itself establish an exemption. Development samples, scent cards and consumer-use products need their own intended-use/supply review. Do not classify every scented paper automatically as a cosmetic.
Can a non-EU company submit a CPNP notification directly?
The legally eligible RP arrangement is distinct from the person operating the portal. The Commission’s guide covers RPs and users acting on their behalf, plus relevant distributors. Administrative assistance by an overseas supplier does not itself establish that supplier as the RP. Confirm authority and access for the actual arrangement.
How long does the CPNP notification take?
Confirm preparation and portal work against the actual data gaps and current instructions. No instant reference or six-to-ten-week total project duration is verified here. A saved draft or submission reference is not an approved product.
What if I sell the same perfume in different bottle sizes?
A notification can cover several pack sizes when its information properly covers the product; page 38 of the current guide explains the associated label/packaging attachment. Have the RP check the actual identity, composition and variants. Neither automatic coverage for all same-brand sizes nor a per-barcode notification rule follows from that guidance.
Can CPNP notification replace the UK’s SCPN?
Distinguish GB from NI. GB uses SCPN, while NI follows the applicable CPNP route. Assess each market and any qualifying-NI-goods arrangements; do not assume a CPNP reference alone covers GB or that NI is outside the CPNP route.
To discuss manufacturing documentation for a European project, Request a Quote. Confirm the actual RP, qualified assessor and authorized notification support separately; no EU-based LAEYO regulatory team or entity is verified here.